Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study

J Am Soc Hypertens. 2012 May-Jun;6(3):193-200. doi: 10.1016/j.jash.2012.01.004. Epub 2012 Feb 16.

Abstract

Although electrocardiographic criteria for diagnosing left ventricular hypertrophy have a low sensitivity in the general population, their test characteristics have not been evaluated in the high-prevalence group of American Americans with chronic kidney disease. The purpose of the current study was to evaluate these test characteristics among African Americans (n = 645) with hypertensive kidney disease as part of the African-American Study of Kidney Disease and Hypertension cohort. Electrocardiograms were read by 2 cardiologists at an independent core laboratory using the 2 Sokolow-Lyon criteria and the Cornell criteria. Left ventricular hypertrophy on echocardiography was defined as left ventricular mass index greater than 49.2 and greater than 46.7 g/m(2.7) in men and women, respectively. Sixty-nine percent of the population had left ventricular hypertrophy on echo, whereas 34% had left ventricular hypertrophy by any of the electrocardiographic criteria. Sensitivity by individual electrocardiographic criteria was 16.5% by Sokolow-Lyon-1, 19.3% by Sokolow-Lyon-2, and 24.7% by Cornell criteria, with specificity ranging from 89% to 92%. When using any of the 3 criteria, sensitivity increased to 40.4% with a decrease in specificity to 78.0%. Consistent with findings in a general population, left ventricular hypertrophy by electrocardiography had low sensitivity and high specificity in this cohort of African Americans with hypertensive kidney disease.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Black or African American*
  • Calcium Channel Blockers / therapeutic use
  • Disease Progression
  • Drug Therapy, Combination
  • Echocardiography / methods*
  • Electrocardiography / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension, Renal / complications*
  • Hypertension, Renal / drug therapy
  • Hypertension, Renal / ethnology
  • Hypertrophy, Left Ventricular / diagnosis*
  • Hypertrophy, Left Ventricular / ethnology
  • Hypertrophy, Left Ventricular / etiology
  • Incidence
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / ethnology*
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • ROC Curve
  • Reproducibility of Results
  • United States / epidemiology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Calcium Channel Blockers